➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Baxter
Harvard Business School
Johnson and Johnson
Mallinckrodt

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Insulin lispro protamine recombinant; insulin lispro recombinant - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for insulin lispro protamine recombinant; insulin lispro recombinant

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Universidad de GuanajuatoPhase 4
Medical University of GrazPhase 1
Eli Lilly and CompanyPhase 3

See all insulin lispro protamine recombinant; insulin lispro recombinant clinical trials

Patent Text Search: US Patents for insulin lispro protamine recombinant; insulin lispro recombinant

These patents were identified by searching patent claims

Supplementary Protection Certificates for insulin lispro protamine recombinant; insulin lispro recombinant

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2005 00018 Denmark   Start Trial PRODUCT NAME: INSULIN GLULISIN
2107069/02 Switzerland   Start Trial PRODUCT NAME: INSULIN DEGLUDEC + INSULIN ASPART; REGISTRATION NO/DATE: SWISSMEDIC 62648 12.09.2013
17/022 Ireland   Start Trial PRODUCT NAME: A COMPOSITION COMPRISING INSULIN GLARGINE, OR A PHARMACOLOGICALLY TOLERABLE SAFT THEREOF, AND LIXISENATIDE, OR A PHARMACOLOGICALLY TOLERABLE SALT THEREOF.; REGISTRATION NO/DATE: EU/1/16/1157 20170111
41/2005 Austria   Start Trial PRODUCT NAME: NOVOMIX 70 - SUSPENSION, ENTHALTEND LÖSLICHES INSULIN ASPART UND PROTAMINKRISTALLISIERTES INSULIN ASPART IM VERHÄLTNIS 70:30
34/2000 Austria   Start Trial PRODUCT NAME: LANTUS - INSULIN GLARGIN
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Baxter
Merck
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.